Severe neurological disabilities after complete remission of advanced malignant melanoma following fotemustine therapy in combination with total brain irradiation

被引：6
|
作者：
Gruss, C [1 ]
Geissler, A
Schalke, B
Landthaler, M
Stolz, W
机构：
[1] Univ Regensburg, Dept Dermatol, D-93042 Regensburg, Germany
[2] Univ Regensburg, Dept Radiol, D-93042 Regensburg, Germany
[3] Univ Regensburg, Dept Neurol, D-93042 Regensburg, Germany
来源：
MELANOMA RESEARCH | 2002年 / 12卷 / 04期
关键词：
D O I：
10.1097/00008390-200208000-00015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：403 / 404
页数：2
相关论文
共 14 条
  • [1] Severe neurological disabilities after complete remission of advanced malignant melanoma following fotemustine therapy in combination with total brain irradiation
    Gruss, C
    Geissler, A
    Schalke, B
    Landthaler, M
    Stolz, W
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 296 - 296
  • [2] Fotemustine given simultaneously with total brain irradiation in multiple brain metastases of malignant melanoma: Report an a pilot study
    Brocker, EB
    Bohndorf, W
    Kampgen, E
    Trcka, J
    Messer, P
    Tilgen, W
    Engenhart, K
    Flentje, M
    MELANOMA RESEARCH, 1996, 6 (05) : 399 - 401
  • [3] Chemosensitivity of malignant melanoma models: Longterm complete remission after regional hyaluronidase/vinblastine therapy
    Spruss, T
    Bernhardt, G
    IMMUNODEFICIENT ANIMALS: MODELS FOR CANCER RESEARCH, 1996, 51 : 145 - 150
  • [4] Nivolumab and Ipilimumab Combination in Patients with multiple symptomatic Brain Metastases - Complete Remission of severe neurological Side Effects
    Becker, S.
    Meier, F.
    Meisterfeld, S.
    Beissert, S.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 52 - 52
  • [5] Partial Remission of advanced Melanoma by Combination Therapy with Nivolumab and Trametinib after Treatment Failure with Ipilimumab plus Nivolumab
    Zaremba, A.
    Chorti, E.
    Jockenhoefer, F.
    Albrecht, M.
    Placke, J. M.
    Knispel, S.
    Schadendorf, D.
    Hadaschik, E.
    Roesch, A.
    Ugurel, S.
    Zimmer, L.
    Livingstone, E.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 38 - 38
  • [6] Complete remission of cutaneous satellite and in-transit metastases.: After intralesional therapy with interleukin-2 in two patients with malignant melanoma
    Pföhler, C
    Steinhäuser, S
    Wagner, A
    Ugurel, S
    Tilgen, W
    HAUTARZT, 2004, 55 (02): : 171 - 175
  • [7] Case Report: Successful liver transplantation after achieving complete clinical remission of advanced HCC with Atezolizumab plus Bevacizumab combination therapy
    Chouik, Yasmina
    Erard, Domitille
    Demian, Hassan
    Schulz, Thomas
    Mazard, Tessa
    Hartig-Lavie, Kerstin
    Antonini, Teresa
    Mabrut, Jean-Yves
    Mohkam, Kayvan
    Rode, Agnes
    Merle, Philippe
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [8] Sustained complete remission of a hepatic metastatic uveal melanoma after immune combination therapy in an HLA-A*02:01-positive patient
    Cramer, C.
    Amschler, K.
    Cihan-Cetin, Y.
    Woerschhauser, L.
    Schoen, M. P.
    Thoms, K. M.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 82 - 83
  • [9] Role of nivolumab maintenance therapy in advanced melanoma patients following severe immune-related adverse events from combination nivolumab and ipilimumab.
    Maloney, Anna
    Giobbie-Hurder, Anita
    Fogarasi, Miklos C.
    Ott, Patrick Alexander
    Hodi, F. Stephen
    Sussman, Tamara A.
    Silk, Ann W.
    Haq, Rizwan
    Liu, David
    Insco, Megan Leigh
    Buchbinder, Elizabeth Iannotti
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Complete Remission of Relapsed Hodgkin's Lymphoma following Brentuximab Vedotin and Gemcitabine Combination Therapy with Severe Hypotension as Possible Treatment-Related Adverse Event: A Case Report
    Purwanto, Ibnu
    Utomo, Bambang P.
    Ghozali, Ahmad
    CASE REPORTS IN ONCOLOGY, 2020, 13 (01): : 341 - 346
12